• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症标志物与昏迷的院外心脏骤停复苏患者生存率之间的关联。

Association between inflammatory markers and survival in comatose, resuscitated out-of-hospital cardiac arrest patients.

作者信息

Toftgaard Pedersen Anne, Kjaergaard Jesper, Hassager Christian, Frydland Martin, Hartvig Thomsen Jakob, Klein Anika, Schmidt Henrik, Møller Jacob Eifer, Wiberg Sebastian

机构信息

Department of Cardiology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.

Department of Clinical Medicine, Copenhagen University, Copenhagen, Denmark.

出版信息

Scand Cardiovasc J. 2022 Dec;56(1):85-90. doi: 10.1080/14017431.2022.2074093.

DOI:10.1080/14017431.2022.2074093
PMID:35546563
Abstract

OBJECTIVES

Prognostication after out-of-hospital cardiac arrest (OHCA) remains challenging. The inflammatory response after OHCA has been associated with increased mortality. This study investigates the associations and predictive value between inflammatory markers and outcome in resuscitated OHCA patients.

DESIGN

The study is based on post hoc analyses of a double-blind controlled trial, where resuscitated OHCA patients were randomized to receive either exenatide or placebo. Blood was analyzed for levels of inflammatory markers the day following admission. Primary endpoint was time to death for up to 180 days. Secondary endpoints included 180-day mortality and poor neurological outcome after 180 days, defined as a cerebral performance category (CPC) of 3 to 5.

RESULTS

Among 110 included patients we found significant associations between higher leucocyte quartile and increasing mortality in univariable analysis (OR 2.6 (95%CI 1.6-4.2),  < .001), as well as in multivariable analysis (OR 2.1 (95%CI 1.1-4.0),  = .02). A significant association was found between higher neutrophil quartile and increasing mortality in univariable analysis (OR 3.0 (95%CI 1.8-5.0),  < .001) as well as multivariable analysis (OR 2.4 (95%CI 1.2-4.6),  = .01). Leucocyte and neutrophil levels were predictive of poor outcome after 180 days with area under the receiver operating characteristics curves of 0.79 and 0.81, respectively. We found no associations between CRP and lymphocyte levels versus outcome.

CONCLUSIONS

Total leucocyte count and neutrophil levels measured the first day following OHCA were significantly associated with 180-day all-cause mortality and may potentially act as early predictors of outcome.

CLINICAL TRIAL REGISTRATION

www.clinicaltrials.gov, unique identifier: NCT02442791.

摘要

目的

院外心脏骤停(OHCA)后的预后评估仍然具有挑战性。OHCA后的炎症反应与死亡率增加有关。本研究调查了复苏的OHCA患者炎症标志物与预后之间的关联及预测价值。

设计

该研究基于一项双盲对照试验的事后分析,复苏的OHCA患者被随机分配接受艾塞那肽或安慰剂。入院次日分析血液中的炎症标志物水平。主要终点是长达180天的死亡时间。次要终点包括180天死亡率和180天后不良神经功能结局,定义为脑功能分类(CPC)为3至5级。

结果

在110例纳入患者中,我们发现在单变量分析中较高的白细胞四分位数与死亡率增加之间存在显著关联(OR 2.6(95%CI 1.6 - 4.2),P <.001),在多变量分析中也是如此(OR 2.1(95%CI 1.1 - 4.0),P = .02)。在单变量分析中较高的中性粒细胞四分位数与死亡率增加之间存在显著关联(OR 3.0(95%CI 1.8 - 5.0),P <.001)以及多变量分析(OR 2.4(95%CI 1.2 - 4.6),P = .01)。白细胞和中性粒细胞水平可预测180天后的不良结局,受试者工作特征曲线下面积分别为0.79和0.81。我们未发现CRP和淋巴细胞水平与预后之间存在关联。

结论

OHCA后第一天测量的白细胞总数和中性粒细胞水平与180天全因死亡率显著相关,可能作为结局的早期预测指标。

临床试验注册

www.clinicaltrials.gov,唯一标识符:NCT02442791。

相似文献

1
Association between inflammatory markers and survival in comatose, resuscitated out-of-hospital cardiac arrest patients.炎症标志物与昏迷的院外心脏骤停复苏患者生存率之间的关联。
Scand Cardiovasc J. 2022 Dec;56(1):85-90. doi: 10.1080/14017431.2022.2074093.
2
Neuroprotective Effects of the Glucagon-Like Peptide-1 Analog Exenatide After Out-of-Hospital Cardiac Arrest: A Randomized Controlled Trial.胰高血糖素样肽-1 类似物艾塞那肽对院外心脏骤停后神经保护作用的随机对照试验。
Circulation. 2016 Dec 20;134(25):2115-2124. doi: 10.1161/CIRCULATIONAHA.116.024088. Epub 2016 Nov 12.
3
Interleukin-6 Receptor Antibodies for Modulating the Systemic Inflammatory Response after Out-of-Hospital Cardiac Arrest (IMICA): study protocol for a double-blinded, placebo-controlled, single-center, randomized clinical trial.白细胞介素-6 受体抗体调节院外心脏骤停后全身炎症反应(IMICA)的研究方案:一项双盲、安慰剂对照、单中心、随机临床试验。
Trials. 2020 Oct 20;21(1):868. doi: 10.1186/s13063-020-04783-4.
4
Steroid treatment as anti-inflammatory and neuroprotective agent following out-of-hospital cardiac arrest: a randomized clinical trial.院外心脏骤停后类固醇治疗作为抗炎和神经保护剂:一项随机临床试验。
Trials. 2022 Nov 22;23(1):952. doi: 10.1186/s13063-022-06838-0.
5
Inflammatory response after prehospital high-dose glucocorticoid to patients resuscitated from out-of-hospital cardiac arrest: A sub-study of the STEROHCA trial.院外心脏骤停患者接受院前大剂量糖皮质激素治疗后的炎症反应:STEROHCA 试验的一个子研究。
Resuscitation. 2024 Sep;202:110340. doi: 10.1016/j.resuscitation.2024.110340. Epub 2024 Jul 31.
6
The predictive value of soluble urokinase plasminogen activator receptor (SuPAR) regarding 90-day mortality and 12-month neurological outcome in critically ill patients after out-of-hospital cardiac arrest. Data from the prospective FINNRESUSCI study.可溶性尿激酶型纤溶酶原激活物受体(SuPAR)对院外心脏骤停后重症患者90天死亡率和12个月神经功能结局的预测价值。来自前瞻性FINNRESUSCI研究的数据。
Resuscitation. 2014 Nov;85(11):1562-7. doi: 10.1016/j.resuscitation.2014.08.017. Epub 2014 Sep 2.
7
Effect of prehospital high-dose glucocorticoid on hemodynamics in patients resuscitated from out-of-hospital cardiac arrest: a sub-study of the STEROHCA trial.院前高剂量糖皮质激素对心肺复苏后患者血流动力学的影响:STEROHCA 试验的子研究。
Crit Care. 2024 Jan 22;28(1):28. doi: 10.1186/s13054-024-04808-3.
8
Predicting neurological outcome after out-of-hospital cardiac arrest with cumulative information; development and internal validation of an artificial neural network algorithm.利用累积信息预测院外心脏骤停后的神经功能结局;人工神经网络算法的开发和内部验证。
Crit Care. 2021 Feb 25;25(1):83. doi: 10.1186/s13054-021-03505-9.
9
Markers of neutrophil mediated inflammation associate with disturbed continuous electroencephalogram after out of hospital cardiac arrest.中性粒细胞介导的炎症标志物与院外心脏骤停后脑电图连续紊乱有关。
Acta Anaesthesiol Scand. 2023 Jan;67(1):94-103. doi: 10.1111/aas.14145. Epub 2022 Sep 12.
10
Design paper of the "Blood pressure targets in post-resuscitation care and bedside monitoring of cerebral energy state: a randomized clinical trial".“复苏后护理和床边监测脑能量状态中的血压目标:一项随机临床试验”的设计方案。
Trials. 2019 Jun 10;20(1):344. doi: 10.1186/s13063-019-3397-1.

引用本文的文献

1
Association of white blood cell count with one-year mortality after cardiac arrest.心脏骤停后白细胞计数与一年死亡率的关联。
Resusc Plus. 2024 Nov 2;20:100816. doi: 10.1016/j.resplu.2024.100816. eCollection 2024 Dec.
2
EPOS-OHCA: Early Predictors of Outcome and Survival after non-traumatic Out-of-Hospital Cardiac Arrest.院外心脏骤停后结局和生存的早期预测因素:非创伤性院外心脏骤停研究(EPOS-OHCA)
Resusc Plus. 2024 Jul 24;19:100728. doi: 10.1016/j.resplu.2024.100728. eCollection 2024 Sep.
3
The relationship between the level of NMLR on admission and the prognosis of patients after cardiopulmonary resuscitation: a retrospective observational study.
入院时 NMLR 水平与心肺复苏后患者预后的关系:一项回顾性观察研究。
Eur J Med Res. 2023 Oct 11;28(1):424. doi: 10.1186/s40001-023-01407-w.
4
Comparison of Prognostic Performance between Procalcitonin and Procalcitonin-to-Albumin Ratio in Post Cardiac Arrest Syndrome.心脏骤停后综合征中降钙素原与降钙素原-白蛋白比值预后性能的比较
J Clin Med. 2023 Jul 9;12(14):4568. doi: 10.3390/jcm12144568.
5
Cell-Free Double-Stranded DNA to DNase Ratio Predicts Outcome after Primary Survived Cardiac Arrest.无细胞双链 DNA 与脱氧核糖核酸酶比值可预测原发性心脏骤停后患者的预后。
Cells. 2022 Oct 25;11(21):3367. doi: 10.3390/cells11213367.